BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 29, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 8, 2011
View Archived Issues
Nicotinic acetylcholine alpha5 receptor may represent new target of smoking cessation therapies
Read More
FDA grants accelerated approval to Hologic's Makena to reduce risk of preterm delivery
Read More
Snapshots: Recent clinical trials of briakinumab in psoriasis
Read More
Apremilast reduces severity of psoriasis and improves quality of life
Read More
Galapagos receives IWT grant for antiviral drug discovery
Read More
Merck & Co. reviews operations of fourth quarter 2010
Read More
TEAM trial compares exemestane alone to sequential tamoxifen/exemestane therapy in breast cancer
Read More
Algenpantucel-L plus adjuvant therapy improves survival of patients with resected pancreatic cancer
Read More
Combination of 90Y-hPAM4 and gemcitabine shows promise in advanced pancreatic cancer
Read More
TC-5214 enters phase IIb trial in major depressive disorder
Read More
Depomed reports phase I data on DM-1992 in Parkinson's disease
Read More
Helix BioPharma clear to conduct phase I L-DOS-47 trial in U.S.
Read More
Progenics and Salix Pharma enter into license agreement for Relistor
Read More
Harbor BioSciences completes phase I/IIa Apoptone trial in prostate cancer
Read More
Cell culture model mimics breast ductal system for design of nanoparticle therapies and diagnostics
Read More
Optimer Pharma and Astellas enter agreement for antibiotic fidaxomicin
Read More
Phosphagenics enters agreement to develop TPM-delivered antipsoriasis drug
Read More
Pharmaxis' Bronchitol approved in Australia for cystic fibrosis
Read More
NMS describes in silico model to predict myelosuppressive activity of drugs
Read More
Third phase III Avastin trial in ovarian cancer meets primary endpoint
Read More
FDA approves labeling update to Reyataz for HIV-infected pregnant women
Read More
Ansaris earns milestone payment from Ono Pharma with identification of kinase-related agent
Read More
Lundbeck is granted rights to several Cephalon products in Canada and Latin America
Read More
GSK adds new safety information and restrictions on use to rosiglitazone-containing medicines
Read More
